Venture and Growth Equity

SCML invests in innovative businesses across all stages of the growth spectrum

Life Sciences Pulse

Our life sciences strategy looks to invest in promising life sciences companies that we believe are at the heart of a technological and scientific revolution in healthcare.

Life Sciences Pulse

Global Innovation

Our Global Innovation strategy is at the nexus of public and private markets and aims to invest in the best private technology business with the potential to become leading public companies.

Global Innovation

Global Ventures

Our Global Ventures strategy seeks to partner with entrepreneurs building transformational early-stage technology businesses.

Global Ventures

“They know where the market is heading and what it needs. It has been a complete alignment with our vision.”

Ajay Khanna Founder & CEO, Tellius

“They know where the market is heading and what it needs. It has been a complete alignment with our vision.”

Ajay Khanna Founder & CEO, Tellius

SCML is an active, long-term investor in leading innovative growth businesses, globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning alternatives, growth equity and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.

An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, SCML managed $59B in client assets as of September 30, 2025.

For institutional and professional investors only. Investment advisory fees are described in Part II of the adviser’s Form ADV .

Our Culture

Our People

News & Events

Careers

Uncovering Europe’s Next Generation of Global Leaders

Revolutionizing Public Safety: The Axon Ecosystem

Obvious. Difficult. Repeatable.

FPT Harnesses Education to Transform Talent Landscape

Philosophy & Approach

Stewardship

Public Equity